Skip to main content
Clinical Trials/NCT04976907
NCT04976907
Unknown
Not Applicable

Peri-operative Mobile Application for Contactless Screening and Vital Signs Measurement (MAC-VITAL): A Proof of Concept Trial

Nuralogix Corporation4 sites in 1 country200 target enrollmentOctober 1, 2021
ConditionsVital Signs

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Vital Signs
Sponsor
Nuralogix Corporation
Enrollment
200
Locations
4
Primary Endpoint
Systolic blood pressure difference from reference measurement (mmHg)
Last Updated
4 years ago

Overview

Brief Summary

The impact of the coronavirus disease (COVID)-19 pandemic on global healthcare systems has prompted a search for novel tools to stem the tide. New digital health tools can provide possible health solutions in this time of unprecedented medical crisis to mitigate the impact of this pandemic. This proof of concept study will determine the feasibility and effectiveness of implementing a mobile application for contactless screening and vital signs measurement (MAC-VITAL) such as blood pressure (BP), heart rate (HR), respiratory rate (RR), oxyhemoglobin saturation (SpO2), temperature from surgical patients peri-operatively. Contactless measurement of vital signs will bridge the current gap between virtual care and in-person medical assessments.

Detailed Description

This study aims to determine whether a mobile app can accurately and reliably measure vital signs without any person to person contact, and the feasibility of implementing it in a peri-operative setting (e.g., during COVID-19). The validity and feasibility of the Anura™ Research app will be assessed during inpatient visits in preparation for and after surgery, and it will be compared with standard medical monitors.

Registry
clinicaltrials.gov
Start Date
October 1, 2021
End Date
October 1, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients scheduled to undergo elective surgery under general and/or regional anesthesia
  • 18+ years of age

Exclusion Criteria

  • Refusal to consent for the study
  • Non-English speaking

Outcomes

Primary Outcomes

Systolic blood pressure difference from reference measurement (mmHg)

Time Frame: Perioperative

Assessed against standard clinical grade instrument: automated oscillometric blood pressure device (mmHg)

Diastolic blood pressure difference from reference measurement (mmHg)

Time Frame: Perioperative

Assessed against standard clinical grade instrument: automated oscillometric blood pressure device (mmHg)

Blood oxygenation (SpO2) difference from reference measurement (% oxyhemoglobin saturation)

Time Frame: Perioperative

Assessed against standard clinical grade instrument: Finger-based pulse oximeter (% oxyhemoglobin saturation)

Pulse rate difference from reference measurement (beats per minute)

Time Frame: Perioperative

Assessed against standard clinical grade instrument: Finger-based pulse oximeter (beats per minute)

Teperature difference from reference measurement (degrees Celsius)

Time Frame: Perioperative

Assessed against standard clinical grade instrument: Forehead digital thermometer (degrees Celsius)

Respiratory rate difference from reference measurement (breaths per minute)

Time Frame: Perioperative

Assessed against standard clinical grade instrument: Visual count of chest rise and fall (breaths per minute)

Obstacles to using the mobile application

Time Frame: Perioperative

Characterization of obstacles to the implementation of the mobile app for perioperative vital sign measurements.

Secondary Outcomes

  • Detection rate of clinically meaningful changes of vital signs(Perioperative)
  • Ease of use survey(Perioperative)
  • Satisfaction survey(Perioperative)
  • Study participation(Perioperative)
  • Compliance with measurement protocol(Perioperative)

Study Sites (4)

Loading locations...

Similar Trials